Brief: Sino Biopharmaceutical Posts FY Profit Attributable RMB2.33 Billion
28/03/2024 09:33
March 28 (Reuters) - Sino Biopharmaceutical Ltd
1177.HK :
* FY PROFIT ATTRIBUTABLE RMB2.33 BILLION VERSUS RMB2.54
BILLION
* FINAL DIVIDEND HK3 CENTS PER SHARE
* FY REVENUE RMB26.20 BILLION
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up